Treatment effectiveness is assessed at product-specific timepoints, with continuation based on achieving predetermined weight loss targets
These work through different mechanisms than GLP-1 receptor agonists
One of Retatrutides three receptor targets
Your provider may recommend pairing Tirzepatide with nutrition counseling, physical activity, and behavior modification to support long-term success
Stopping Semaglutide or Tirzepatide is safe and common, though you may experience increased appetite and weight gain
Who should avoid Tirzepatide: Tirzepatide (Mounjaro, Zepbound) carries similar restrictions and is contraindicated in: Individuals with a personal or family history of MTC Those with MEN 2, due to the same cancer-related concerns People who have experienced severe gastrointestinal issues, such as chronic pancreatitis or gastroparesis Patients with a known hypersensitivity to tirzepatide or any of its components As always, anyone considering these medications should talk with their healthcare provider about their personal health history and risk factors